Bd reports second quarter fiscal 2023 financial results

Bd 2025 strategic investments driving growth and advancing innovation; company raises mid-point of revenue and adjusted eps guidance ranges revenue of $4.8 billion increased 1.5% as reported and 4.1% on a currency-neutral basis revenue from base business (which excludes covid-only diagnostic testing) grew 6.0% as reported, 8.7% currency-neutral gaap and adjusted diluted eps from continuing operations of $1.53 and $2.86, respectively company raises full-year base revenue guidance, enabling additional investments in growth and innovation while absorbing lower covid-only diagnostic testing revenue and incremental fx impacts franklin lakes, n.j. , may 4, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its second quarter of fiscal 2023, which ended march 31, 2023.
BDX Ratings Summary
BDX Quant Ranking